Hewlett-Packard ties in Aspect's technology:
This article was originally published in Clinica
Hewlett-Packard is to integrate Aspect Medical Systems' Bispectral Index (BIS) technology into its Viridia 24/265 and Viridia CMS patient monitors under a worldwide licensing agreement. Non-invasive BIS monitoring provides a direct measurement of the effects of anaesthesia on the brain, via a sensor placed on the forehead to capture EEG signals. Under the agreement, HP will assist in the distribution of Aspect's stand-alone A-2000 BIS monitor and BIS sensors outside the US. Separately, HP has announced that its test and measurement company, which is being spun-off from the computer and printer business, will be called Agilent Technologies.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.